PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM)
CUSIP: 70387R403
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 6,367,621
- Total 13F shares
- 1,120,689
- Share change
- +64,018
- Total reported value
- $1,378,717
- Price per share
- $1.23
- Number of holders
- 22
- Value change
- +$95,825
- Number of buys
- 5
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 70387R403?
CUSIP 70387R403 identifies PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 70387R403:
Top shareholders of PAVM - PAVmed Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
7.9%
|
500,000
|
$407,500 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.6%
|
295,390
|
$240,743 | — | 30 Jun 2024 | |
| Axiom Advisory, LLC |
13F
|
Company |
0.61%
|
38,955
|
$70,714 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.2%
|
74,912
|
$61,053 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
73,634
|
$60,025 | — | 30 Jun 2024 | |
| James L. Cox |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| Joan B. Harvey |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.4%
|
25,225
|
$20,558 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.33%
|
20,854
|
$16,996 | — | 30 Jun 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.24%
|
15,099
|
$12,000 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
11,706
|
$9,540 | — | 30 Jun 2024 | |
| XML Financial, LLC |
13F
|
Company |
0.16%
|
10,067
|
$8,205 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.15%
|
9,704
|
$7,908 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
5,068
|
$4,130 | — | 30 Jun 2024 | |
| CWM, LLC |
13F
|
Company |
0.07%
|
4,672
|
$4,000 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
5,395
mixed-class rows
|
$3,920 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.06%
|
3,902
|
$3,181 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
42,208
|
$844 | — | 30 Jun 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
836
|
$664 | — | 30 Jun 2024 | |
| Allworth Financial LP |
13F
|
Company |
0.01%
|
420
|
$425 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
116
|
$94 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
179
mixed-class rows
|
$67 | — | 30 Jun 2024 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
78
|
$64 | — | 30 Jun 2024 | |
| M&R CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
67
|
$55 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
37
|
$30 | — | 30 Jun 2024 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
7
|
$6 | — | 30 Jun 2024 | |
| THOMPSON INVESTMENT MANAGEMENT, INC. |
13F
|
Company |
0%
|
4
|
$3 | — | 30 Jun 2024 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Jun 2024 | |
| Brian J. DeGuzman |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
50,000
|
— | — | 18 Feb 2022 |
Institutional Holders of PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) as of Q3 2024
As of 30 Sep 2024,
PAVmed Inc. - Common Stock, par value $0.001 per share (PAVM) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,120,689 shares.
The largest 10 holders included
FIRST MANHATTAN CO. LLC., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., OBERMEYER WOOD INVESTMENT COUNSEL, LLLP, STATE STREET CORP, NORTHERN TRUST CORP, XML Financial, LLC, MORGAN STANLEY, and CWM, LLC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
23
Q3 2024 holders
22
Holder diff
-1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.